Balance Sheet
Accumulated DepreciationAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReal Estate - GrossReal Estate - NetReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PA) Intangibles (2016 - 2025)

Historic Intangibles for Global Medical REIT (GMRE-PA) over the last 10 years, with Q3 2025 value amounting to $144.7 million.

  • Global Medical REIT's Intangibles rose 493.89% to $144.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $144.7 million, marking a year-over-year increase of 493.89%. This contributed to the annual value of $138.9 million for FY2024, which is 23.66% up from last year.
  • Per Global Medical REIT's latest filing, its Intangibles stood at $144.7 million for Q3 2025, which was up 493.89% from $147.4 million recorded in Q2 2025.
  • In the past 5 years, Global Medical REIT's Intangibles ranged from a high of $148.2 million in Q1 2023 and a low of $103.3 million during Q1 2021
  • In the last 5 years, Global Medical REIT's Intangibles had a median value of $138.6 million in 2023 and averaged $136.4 million.
  • As far as peak fluctuations go, Global Medical REIT's Intangibles soared by 3548.13% in 2021, and later crashed by 649.72% in 2024.
  • Over the past 5 years, Global Medical REIT's Intangibles (Quarter) stood at $127.9 million in 2021, then increased by 15.75% to $148.1 million in 2022, then fell by 6.39% to $138.6 million in 2023, then grew by 0.24% to $138.9 million in 2024, then increased by 4.14% to $144.7 million in 2025.
  • Its Intangibles stands at $144.7 million for Q3 2025, versus $147.4 million for Q2 2025 and $141.8 million for Q1 2025.